Massachusetts Medical Society: Coalition Letter in Support of 51A Reform for Prenatal Substance Exposure

Coalition Letter in Support of 51A Reform for Prenatal Substance Exposure

Chair Adrian Madaro
Chair Brendan Crighton
Rep. Alice Peisch
Chair John Velis
Rep. Michael Soter
Senator Ryan Fattman

Re: Support for 51A reform for prenatal substance exposure

Dear Chair Madaro, Chair Crighton and Members of the Conference Committee,

Thank you for your leadership on many fronts related to substance use disorder, including improving the care of those living with addiction and your support of people in recovery. We are grateful that both the House and Senate passed legislation addressing the opioid epidemic this session. As you work to craft final substance use legislation, our coalition of medical providers, policy experts, and people with lived experience urge you to include reforms to 51A reporting on prenatal substance exposure.

Legislation to address this issue was filed in both chambers and favorably reported by the Joint Committee on Children, Families, and Persons with Disabilities after extensive engagement with stakeholders, including all relevant state agencies. The provisions before the conference committee would update the 51A filing requirements to reflect current best practices in addiction treatment and continue to center the wellbeing of children and families. This policy strikes a balanced approach, achieves meaningful reform, and brings Massachusetts in line with all other New England states.

The legislation would: ensure that 51A abuse and neglect reports are not required based on mere prenatal substance exposure alone without other indicia of abuse and neglect; prompt the development of guidance for health care providers regarding prenatal substance exposure; create dual-track reporting for substance exposure consistent with the federal Child Abuse Prevention and Treatment Act so that de-identified data is provided by DPH to DCF; and task DPH in consultation with DCF and the Office of the Child Advocate with studying these changes and recommending any further reforms needed.

There is broad consensus among hospitals, medical providers, families with lived experience, advocates AND the relevant state agencies that the Commonwealth needs to update 51A reporting for substance exposed newborns. We urge you to send the Governor a final substance use and recovery bill that includes these critical reforms before the end of the 2023- 2024 legislative session.

Sincerely,

ACLU of Massachusetts
Boston Medical
Center Mass General Brigham
Massachusetts Health and Hospital
Association Massachusetts Law Reform
Institute Massachusetts Medical Society
Massachusetts Organization for Addiction Recovery
Massachusetts Society of Addiction Medicine
Massachusetts Public Health Association


Cc: Speaker Mariano
Senate President Spilka

View a PDF of this letter here.

Share on Facebook

2024 Legislative Update

MMS President Dr. Hugh Taylor and the MMS advocacy team provided a special state legislative update on Oct. 15, 2024. View a recording of this webinar to learn the latest developments from Beacon Hill.

Find Your Legislator

Click here to enter your address and get a list of your federal representatives, state legislators, and your local polling place.

Find Your Legislator »

State and Federal Agencies

State House - Mass. State AgenciesRapid access to relevant resources from State and Federal health care agencies for Massachusetts physicians.

Massachusetts State Agencies
Federal Agencies

Facebook logoLinkedInYouTube logoInstagramThreads

Copyright © 2024. Massachusetts Medical Society, 860 Winter Street, Waltham Woods Corporate Center, Waltham, MA 02451-1411

(781) 893-4610 | General Support: (617) 841-2925 or support@mms.org